InvestorsHub Logo
Followers 31
Posts 5981
Boards Moderated 0
Alias Born 04/20/2010

Re: alphapuppy post# 711500

Thursday, 08/08/2024 11:38:26 AM

Thursday, August 08, 2024 11:38:26 AM

Post# of 715508
The National Brain Tumor Society has GBM 5 year survival at 6.9%

The Jama paper has 5 year survival of all who received DCVax at 9.1 percent. That's after weeding out the sick ones who didn't even qualify for the trial. You don't think selection criteria can increase 5 year survival by 2%? Considering GTR is a huge factor in OS, and the P3 weeded out incomplete resection, 2% is probable for the P3 patients. Most likely well over that.

So where is this "long tail" from DCVax again?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News